New drug prolongs ALS patient survival in trial

An experimental medication that was recently shown to slow the progression of ALS has now demonstrated the potential to also prolong patient survival.

Harvard Gazette • harvard
Oct. 16, 2020 ~4 min

Tags: harvard-medical-school health-medicine als massachusetts-general-hospital mgh lou-gehrigs-disease sean-m-healey-amg-center-for-als

Page 1 of 1